Cargando…

A novel pyroptosis-related lncRNA signature for prognostic prediction in patients with lung adenocarcinoma

Lung adenocarcinoma (LUAD) has been the major cause of tumor-associated mortality in recent years and has a poor prognosis. Pyroptosis is regulated via the activation of inflammasomes and participates in tumorigenesis. However, the effects of pyroptosis-related lncRNAs (PRlncRNAs) on LUAD have not y...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Jiahang, Sun, Yuanyuan, Cao, Hui, Liu, Zhengcheng, Xi, Lei, Dong, Changqing, Yang, Rusong, Shi, Ye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806662/ https://www.ncbi.nlm.nih.gov/pubmed/34488540 http://dx.doi.org/10.1080/21655979.2021.1972078

Ejemplares similares

Pyroptosis-Related LncRNA Signatures Correlate With Lung Adenocarcinoma Prognosis
por: Huang, Hua, et al.
Publicado: (2022)

Identification and Validation of a Three Pyroptosis-Related lncRNA Signature for Prognosis Prediction in Lung Adenocarcinoma
por: Liu, Jichang, et al.
Publicado: (2022)

Echinacoside Induces Mitochondria-Mediated Pyroptosis through Raf/MEK/ERK Signaling in Non-Small Cell Lung Cancer Cells
por: Shi, Ye, et al.
Publicado: (2022)

A novel prognostic signature of immune-related lncRNA pairs in lung adenocarcinoma
por: Liu, Yang, et al.
Publicado: (2021)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021)

Prognostic pyroptosis-related lncRNA signature predicts the efficacy of immunotherapy in hepatocellular carcinoma
por: Cheng, Zina, et al.
Publicado: (2022)

Analysis of Pyroptosis-Related Immune Signatures and Identification of Pyroptosis-Related LncRNA Prognostic Signature in Clear Cell Renal Cell Carcinoma
por: Zhong, Ming, et al.
Publicado: (2022)

Identification of a pyroptosis-related lncRNA signature in the regulation of prognosis, metabolism signals and immune infiltration in lung adenocarcinoma
por: Zhou, Shuyi, et al.
Publicado: (2022)

A pyroptosis‐related lncRNA signature in bladder cancer
por: Wang, Peng, et al.
Publicado: (2022)

Differential expression analysis at the individual level reveals a lncRNA prognostic signature for lung adenocarcinoma
por: Peng, Fuduan, et al.
Publicado: (2017)

A novel pyroptosis-related lncRNA prognostic signature associated with the immune microenvironment in lung squamous cell carcinoma
por: Zhou, Wei, et al.
Publicado: (2022)

Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration
por: Wang, Zhengguang, et al.
Publicado: (2022)

Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma
por: Shi, Xiuhui, et al.
Publicado: (2018)

A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma
por: Zhong, Like, et al.
Publicado: (2023)

A Novel Pyroptosis-Related lncRNA Signature for Predicting the Prognosis of Skin Cutaneous Melanoma
por: Xie, Jiaheng, et al.
Publicado: (2021)

Identification of pyroptosis-related lncRNA subtype and signature predicts the prognosis in bladder cancer
por: Zeng, Tao, et al.
Publicado: (2023)

Pyroptosis-related lncRNA pairs to estimate the molecular features and prognostic outcomes of pancreatic ductal adenocarcinoma
por: Lu, Si-Yuan, et al.
Publicado: (2022)

Identification of a prognostic ferroptosis-related lncRNA signature in the tumor microenvironment of lung adenocarcinoma
por: Guo, Yugang, et al.
Publicado: (2021)

Identification and validation of a novel redox-related lncRNA prognostic signature in lung adenocarcinoma
por: Ren, Jie, et al.
Publicado: (2021)

Immune-Related lncRNA Pairs as Prognostic Signature and Immune-Landscape Predictor in Lung Adenocarcinoma
por: Yin, Zhengrong, et al.
Publicado: (2022)

Derivation, Comprehensive Analysis, and Assay Validation of a Pyroptosis-Related lncRNA Prognostic Signature in Patients With Ovarian Cancer
por: Cao, Xueyan, et al.
Publicado: (2022)

Development and validation of a prognostic risk signature for lung adenocarcinoma constructed by six ferroptosis, necroptosis, and pyroptosis-related lncRNAs
por: Peng, Lei, et al.
Publicado: (2022)

A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures
por: Jin, Lipeng, et al.
Publicado: (2020)

Identification of LncRNA Prognostic Signature Associated With Genomic Instability in Pancreatic Adenocarcinoma
por: Zhu, Jinfeng, et al.
Publicado: (2022)

Identification of the Prognostic Significance of Somatic Mutation-Derived LncRNA Signatures of Genomic Instability in Lung Adenocarcinoma
por: Geng, Wei, et al.
Publicado: (2021)

Identification of an Autophagy-Related lncRNA Prognostic Signature and Related Tumor Immunity Research in Lung Adenocarcinoma
por: Chen, Hang, et al.
Publicado: (2021)

Development and Validation of Lactate Metabolism-Related lncRNA Signature as a Prognostic Model for Lung Adenocarcinoma
por: Mai, Shijie, et al.
Publicado: (2022)

Development of six immune‐related lncRNA signature prognostic model for smoking‐positive lung adenocarcinoma
por: Zhou, Dajie, et al.
Publicado: (2022)

The role of pyroptosis-related lncRNA risk signature in ovarian cancer prognosis and immune system
por: Wu, Yanling, et al.
Publicado: (2023)

A Radioresponse-Related lncRNA Biomarker Signature for Risk Classification and Prognosis Prediction in Non-Small-Cell Lung Cancer
por: Song, Jiahang, et al.
Publicado: (2021)

A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma
por: Lu, Yinliang, et al.
Publicado: (2022)

Prognosis and Tumour Immune Microenvironment of Patients With Hepatocellular Carcinoma by a Novel Pyroptosis-Related lncRNA Signature
por: Zhang, Ze, et al.
Publicado: (2022)

Prognostic signature of esophageal adenocarcinoma based on pyroptosis-related genes
por: Li, Guo-Sheng, et al.
Publicado: (2022)

Clinical Significance and Immune Landscape of a Pyroptosis-Derived LncRNA Signature for Glioblastoma
por: Xing, Zhe, et al.
Publicado: (2022)

Identification of pyroptosis-related lncRNA signature and AC005253.1 as a pyroptosis-related oncogene in prostate cancer
por: Yu, JiangFan, et al.
Publicado: (2022)

An immune-related lncRNA signature for the prognosis of pancreatic adenocarcinoma
por: Qi, Bing, et al.
Publicado: (2021)

A novel signature based on autophagy-related lncRNA for prognostic prediction and candidate drugs for lung adenocarcinoma
por: Gong, Zetian, et al.
Publicado: (2022)

Identification of the 3-lncRNA Signature as a Prognostic Biomarker for Colorectal Cancer
por: Liu, Shuzhen, et al.
Publicado: (2020)

KIAA1211 plays an oncogenic role in human non-small cell lung cancer
por: Liu, Zhengcheng, et al.
Publicado: (2019)

A risk stratification and prognostic prediction model for lung adenocarcinoma based on aging-related lncRNA
por: Chen, HuiWei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_73ku54trsdllhtip50mnmrpie8